ATAI Life Sciences N.V.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+21.3M	99.2%	$2.08	+$44.3M
Sells	5	-182K	0.8%	$1.35	-$246K
Net	-4	+21.1M	98.3%		+$44M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Apeiron Investment Group Ltd.	10%+ Owner	$261M	+$44.3M	+20.5%	Sep 30, 2025
Christopher Ryan Cave Barrett	Chief Legal and Business Officer	$732K			Oct 1, 2025
Florian Brand	Co-Founder & Co-Chief Executive Officer	$636K			Oct 4, 2024
Srinivas Rao	Co-Founder and Chief Executive Officer	$292K	-$102K	-25.8%	Aug 13, 2025
Anne Nagengast Johnson	Chief Financial Officer	$189K	-$45.3K	-19.3%	Mar 21, 2025
Sahil Kirpekar	Chief Business Officer	$156K	-$65.6K	-29.6%	Mar 21, 2025
Glenn Frank Short	Chief Scientific Officer	$57.2K	-$17.8K	-23.7%	Mar 21, 2025
Kevin James Craig	Chief Medical Officer	$11.4K	-$15.6K	-57.8%	Mar 21, 2025
Gregory Weaver	Chief Financial Officer	$5.39K			Mar 2, 2022
Alexis de Rosnay	Director	$5.39K			May 25, 2022
Amir H. Kalali	Director				Jun 26, 2025
Laurent Fischer	Director				Jun 26, 2025
John Francis Hoffman	Director				Jun 26, 2025
Scott Braunstein	Director				Jun 26, 2025
Gerd Kochendoerfer	Chief Operating Officer				Jan 2, 2025
Andrea Heslin Smiley	Director				Jun 26, 2025
Jason Camm	Director				May 23, 2023
Sabrina Martucci Johnson	Director				Jun 26, 2025
Michael Auerbach	Director				Jun 13, 2024
Christian Angermayer	Director, 10%+ Owner				Jun 26, 2025
Rolando Gutierrez-Esteinou	Chief Medical Officer				Mar 14, 2023
Stephen Bardin	Chief Financial Officer				Mar 14, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.